Skip to main content
OpenTrials

Clinical trial condition

Coagulation Protein Disorders

Explore clinical trials studying Coagulation Protein Disorders. Study availability and eligibility vary by location and protocol.

784 public trials 106 recruiting studies
Refine in advanced search Browse all conditions

Coagulation Protein Disorders trial results

Completed

A Study of the Use of Factor XIII Concentrate in Patients With Inherited FXIII Deficiency

NCT00883090

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +6 more
Locations
  • Study Site Dothan, Alabama, United States
  • Study Site Orange, California, United States
  • Study Site San Francisco, California, United States
  • Study Site Stockton, California, United States
View Trial Details
Completed

Study Comparing On-Demand Treatment With Two Prophylaxis Regimens Of BeneFIX In Patients With Severe Hemophilia B

NCT00364182

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +7 more
Locations
  • Pfizer Investigational Site Phoenix, Arizona, United States
  • Pfizer Investigational Site Chicago, Illinois, United States
  • Pfizer Investigational Site Chicago, Illinois, United States
  • Pfizer Investigational Site New Brunswick, New Jersey, United States
View all 19 locations
View Trial Details
Completed

Study Evaluating B-Domain Deleted Recombinant Factor VIII (BDDrFVIII, ReFacto AF) in Patients With Hemophilia A Undergoing Elective Major Surgery

NCT00243659

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Cardiovascular Diseases, +9 more
Locations
  • La Jolla, California, United States
  • Detroit, Michigan, United States
  • Detroit, Michigan, United States
  • Chapel Hill, North Carolina, United States
View all 17 locations
View Trial Details
Completed

Study Evaluating On-Demand Treatment With BeneFIX In Chinese Subjects

NCT00866606

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +7 more
Locations
  • Pfizer Investigational Site Guangzhou, China
  • Pfizer Investigational Site Suzhou, Jiangsu, China
  • Pfizer Investigational Site Tianjin, Tianjin Municipality, China
  • Pfizer Investigational Site Hangzhou, Zhejiang, China
View Trial Details
Completed

Study Evaluating Refacto For Pharmacovigilance

NCT00195442

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +6 more
Locations
  • Pfizer Investigational Site Vienna, State of Vienna, Austria
  • Pfizer Investigational Site Berlin, Germany
  • Pfizer Investigational Site Wiesbaden, Germany
  • Pfizer Investigational Site Frankfurt am Main, Hesse, Germany
View all 26 locations
View Trial Details

Related conditions